Articles citing this article

The Citing articles tool gives a list of articles citing the current article.
The citing articles come from EDP Sciences database, as well as other publishers participating in CrossRef Cited-by Linking Program. You can set up your personal account to receive an email alert each time this article is cited by a new article (see the menu on the right-hand side of the abstract page).

Cited article:

Development of a Colorimetric Loop-Mediated Isothermal Amplification Assay for the Detection of Trypanosoma cruzi in Low-Resource Settings

Taylor J. Moehling, Myla D. Worthington, Pui-Yan G. Wong, Season S. Wong and Robert J. Meagher
Diagnostics 14 (11) 1193 (2024)
https://doi.org/10.3390/diagnostics14111193

Synthesis and in vitro biological activity of chalcone derivatives as potential antiparasitic agents

Koketso J. Setshedi, Richard M. Beteck, Kayhan Ilbeigi, Dorien Mabille, Guy Caljon and Lesetja J. Legoabe
Medicinal Chemistry Research 33 (6) 977 (2024)
https://doi.org/10.1007/s00044-024-03235-x

Optimization of benzenesulfonyl derivatives as anti-Trypanosomatidae agents: Structural design, synthesis, and pharmacological assessment against Trypanosoma cruzi and Leishmania infantum

Guilherme Freitas de Lima Hercos, Mariza Gabriela Faleiro de Moura Lodi Cruz, Ana Clara Cassiano Martinho, Daniela de Melo Resende, Danilo Farago Nascimento, Paula Derksen Macruz, Eduardo Jorge Pilau, Silvane Maria Fonseca Murta and Celso de Oliveira Rezende Júnior
Bioorganic & Medicinal Chemistry 105 117736 (2024)
https://doi.org/10.1016/j.bmc.2024.117736

Microencapsulation of Theobroma cacao L polyphenols: A high-value approach with in vitro anti-Trypanosoma cruzi, immunomodulatory and antioxidant activities

Laura Vargas-Munévar, Juan Borja-Fajardo, Angélica Sandoval-Aldana, Wendy Quintero García, Erika Moreno Moreno, Juan Camilo Henriquez, Elena Stashenko, Liliana Torcoroma García and Olimpo García-Beltrán
Biomedicine & Pharmacotherapy 173 116307 (2024)
https://doi.org/10.1016/j.biopha.2024.116307

Structure–Activity Relationships of Novel N -Imidazoylpiperazines with Potent Anti- Trypanosoma Cruzi Activity

Rocío Marisol Espinoza-Chávez, Celso de Oliveira Rezende Júnior, Mariana Laureano de Souza, Ivani Pauli, Marilia Valli, Leonardo Luiz Gomes Ferreira, Rafael Consolin Chelucci, Simone Michelan-Duarte, Renata Krogh, Fernando Bezerra Romualdo da Silva, Fábio Cardoso Cruz, Aldo Sena de Oliveira, Adriano Defini Andricopulo and Luiz Carlos Dias
Future Medicinal Chemistry 16 (3) 253 (2024)
https://doi.org/10.4155/fmc-2023-0185

From proteome to candidate vaccines: target discovery and molecular dynamics-guided multi-epitope vaccine engineering against kissing bug

Faisal F. Albaqami, Ali Altharawi, Hassan N. Althurwi and Khalid M. Alharthy
Frontiers in Immunology 15 (2024)
https://doi.org/10.3389/fimmu.2024.1413893

Targeting Metalloenzymes: The “Achilles’ Heel” of Viruses and Parasites

Dimitrios Moianos, Georgia-Myrto Prifti, Maria Makri and Grigoris Zoidis
Pharmaceuticals 16 (6) 901 (2023)
https://doi.org/10.3390/ph16060901

Comparative microRNA profiling of Trypanosoma cruzi infected human cells

Natalia Rego, María Gabriela Libisch, Carlos Rovira, Juan Pablo Tosar and Carlos Robello
Frontiers in Cellular and Infection Microbiology 13 (2023)
https://doi.org/10.3389/fcimb.2023.1187375

Trypanosoma cruzi, Chagas disease and cancer: putting together the pieces of a complex puzzle

Cintia Daniela Kaufman, Cecilia Farré, Lucía Biscari, Ana Rosa Pérez and Andrés Alloatti
Frontiers in Cell and Developmental Biology 11 (2023)
https://doi.org/10.3389/fcell.2023.1260423

From Benznidazole to New Drugs: Nanotechnology Contribution in Chagas Disease

Daniele Cavalcante Gomes, Thayse Silva Medeiros, Eron Lincoln Alves Pereira, João Felipe Oliveira da Silva, Johny W. de Freitas Oliveira, Matheus de Freitas Fernandes-Pedrosa, Marcelo de Sousa da Silva and Arnóbio Antônio da Silva-Júnior
International Journal of Molecular Sciences 24 (18) 13778 (2023)
https://doi.org/10.3390/ijms241813778

Sex differences in the etiology and burden of heart failure across country income level: analysis of 204 countries and territories 1990–2019

Sunny Wei, J Jamie Miranda, Mamas A Mamas, Liesl J Zühlke, Evan Kontopantelis, Lehana Thabane and Harriette G C Van Spall
European Heart Journal - Quality of Care and Clinical Outcomes 9 (7) 662 (2023)
https://doi.org/10.1093/ehjqcco/qcac088

A mathematical model for Chagas disease transmission with neighboring villages

Daniel J. Coffield, Anna Maria Spagnuolo, Ryan Capouellez and Gabrielle A. Stryker
Frontiers in Applied Mathematics and Statistics 9 (2023)
https://doi.org/10.3389/fams.2023.1225137

Chagas Disease Ecology in the United States: Recent Advances in Understanding Trypanosoma cruzi Transmission Among Triatomines, Wildlife, and Domestic Animals and a Quantitative Synthesis of Vector–Host Interactions

Rachel E. Busselman and Sarah A. Hamer
Annual Review of Animal Biosciences 10 (1) 325 (2022)
https://doi.org/10.1146/annurev-animal-013120-043949

Amazon Rainforest: A Natural Source for New Therapeutic Alternatives against Neglected Tropical Diseases

Soraya da Silva Santos, João Vitor Silva, Pone Kamdem Boniface and Jeanine Giarolla
The Natural Products Journal 12 (6) (2022)
https://doi.org/10.2174/2210315512666220228151415

Climate change and the prevention of cardiovascular disease

Alan P. Jacobsen, Yii Chun Khiew, Eamon Duffy, et al.
American Journal of Preventive Cardiology 12 100391 (2022)
https://doi.org/10.1016/j.ajpc.2022.100391

Frequency of Human Papillomavirus Detection in Chagasic Megaesophagus Associated or Not with Esophageal Squamous Cell Carcinoma

Fernanda Franco Munari, Laura Sichero, Adriana Cruvinel Carloni, et al.
Pathobiology 89 (1) 29 (2022)
https://doi.org/10.1159/000518697

New Amino Naphthoquinone Derivatives as Anti-Trypanosoma cruzi Agents Targeting Trypanothione Reductase

Christian Espinosa-Bustos, Mariana Ortiz Pérez, Alonzo Gonzalez-Gonzalez, et al.
Pharmaceutics 14 (6) 1121 (2022)
https://doi.org/10.3390/pharmaceutics14061121

Impact of IFN-γ Deficiency on the Cardiomyocyte Function in the First Stage of Experimental Chagas Disease

Danilo Roman-Campos, Policarpo Sales-Junior, Alexandre D. Costa, et al.
Microorganisms 10 (2) 271 (2022)
https://doi.org/10.3390/microorganisms10020271

Development of 3D-QSAR and pharmacophoric models to design new anti-Trypanosoma cruzi agents based on 2-aryloxynaphthoquinone scaffold

M. Paulino, C. Espinosa-Bustos, J. Bertrand, et al.
SAR and QSAR in Environmental Research 33 (9) 701 (2022)
https://doi.org/10.1080/1062936X.2022.2120069

Crystal structure of Trypanosoma cruzi heme peroxidase and characterization of its substrate specificity and compound I intermediate

Samuel L. Freeman, Vera Skafar, Hanna Kwon, Alistair J. Fielding, Peter C.E. Moody, Alejandra Martínez, Federico M. Issoglio, Lucas Inchausti, Pablo Smircich, Ari Zeida, Lucía Piacenza, Rafael Radi and Emma L. Raven
Journal of Biological Chemistry 298 (8) 102204 (2022)
https://doi.org/10.1016/j.jbc.2022.102204

Contextual influence on poor self-rated health in patients with Chagas disease: multilevel study

Ariela Mota Ferreira, Ester Cerdeira Sabino, Léa Campos de Oliveira-da Silva, et al.
Ciência & Saúde Coletiva 27 (7) 2827 (2022)
https://doi.org/10.1590/1413-81232022277.01682022

Editorial: Signaling in stress sensing and resistance in parasitic protozoa

Arijit Bhattacharya, Christopher Fernandez-Prada, Guillermo Daniel Alonso and Arunima Biswas
Frontiers in Cellular and Infection Microbiology 12 (2022)
https://doi.org/10.3389/fcimb.2022.962047

Chemical and biological analysis of 4-acyloxy-3-nitrocoumarins as trypanocidal agents

Francisco Salgado, Mauricio Moncada-Basualto, Josue Pozo-Martinez, Ana Liempi, Ulrike Kemmerling, Juan-Diego Maya, Pablo Jaque, Fernanda Borges, Eugenio Uriarte, Maria J. Matos and Claudio Olea-Azar
Arabian Journal of Chemistry 14 (3) 102975 (2021)
https://doi.org/10.1016/j.arabjc.2020.102975

In vitro studies and preclinical evaluation of benznidazole microparticles in the acute Trypanosoma cruzi murine model

Marcela S. Rial, Katia P. Seremeta, Mónica I. Esteva, et al.
Parasitology 148 (5) 566 (2021)
https://doi.org/10.1017/S0031182020002310

A Rapid Review on the Efficacy and Safety of Pharmacological Treatments for Chagas Disease

Cody J Malone, Immaculate Nevis, Eduardo Fernández and Ana Sanchez
Tropical Medicine and Infectious Disease 6 (3) 128 (2021)
https://doi.org/10.3390/tropicalmed6030128

Diaminomaleonitrile Derivatives as new Potential Antichagasic Compounds: A Study of Structure–Activity Relationships

Aldo S de Oliveira, Lucas dos S Mello, Camila H Ogihara, Thiago H Döring, David L Palomino-Salcedo, Simone Michelan-Duarte, Leonardo LG Ferreira, Julia M Souza, María José Dávila-Rodríguez, José W da Cruz Júnior, Edward R Dockal and Adriano D Andricopulo
Future Medicinal Chemistry 13 (24) 2167 (2021)
https://doi.org/10.4155/fmc-2021-0194

Ficolin‐3 in chronic Chagas disease: Low serum levels associated with the risk of cardiac insufficiency

Kárita Cláudia Freitas Lidani, Fabiana Antunes Andrade, Marcia Holsbach Beltrame, Indira Chakravarti, Maria Regina Tizzot, Edneia Oliveira Cavalcanti, Thaisa Lucas Sandri, Paola Rosa Luz and Iara J. Messias‐Reason
Parasite Immunology 43 (6) (2021)
https://doi.org/10.1111/pim.12829

Antikinetoplastid Activity of Sesquiterpenes Isolated from the Zoanthid Palythoa aff. clavata

Carlos J. Bethencourt-Estrella, Nathalia Nocchi, Atteneri López-Arencibia, et al.
Pharmaceuticals 14 (11) 1095 (2021)
https://doi.org/10.3390/ph14111095

Cohort profile update: the main and new findings from the SaMi-Trop Chagas cohort

Claudia Di Lorenzo Oliveira, Clareci Silva Cardoso, Nayara Ragi Baldoni, et al.
Revista do Instituto de Medicina Tropical de São Paulo 63 (2021)
https://doi.org/10.1590/s1678-9946202163075

Immunomodulation and Antioxidant Activities as Possible Trypanocidal and Cardioprotective Mechanisms of Major Terpenes from Lippia alba Essential Oils in an Experimental Model of Chronic Chagas Disease

Denerieth Ximena Espinel-Mesa, Clara Isabel González Rugeles, Julio César Mantilla Hernández, et al.
Antioxidants 10 (11) 1851 (2021)
https://doi.org/10.3390/antiox10111851

Performance Evaluation of a Commercial Real-Time PCR Assay and of an In-House Real-Time PCR for Trypanosoma cruzi DNA Detection in a Tropical Medicine Reference Center, Northern Italy

Silvia Stefania Longoni, Elena Pomari, Alberto Antonelli, Fabio Formenti, Ronaldo Silva, Stefano Tais, Salvatore Scarso, Gian Maria Rossolini, Andrea Angheben and Francesca Perandin
Microorganisms 8 (11) 1692 (2020)
https://doi.org/10.3390/microorganisms8111692

Recent Progress in the Discovery and Development of 2-Nitroimidazooxazines and 6-Nitroimidazooxazoles to Treat Tuberculosis and Neglected Tropical Diseases

Hollis D. Showalter
Molecules 25 (18) 4137 (2020)
https://doi.org/10.3390/molecules25184137

Factors associated with quality of life in patients with Chagas disease: SaMi-Trop project

Nayara Dornela Quintino, Ester Cerdeira Sabino, José Luiz Padilha da Silva, et al.
PLOS Neglected Tropical Diseases 14 (5) e0008144 (2020)
https://doi.org/10.1371/journal.pntd.0008144

A Fluorinated Phenylbenzothiazole Arrests the Trypanosoma cruzi Cell Cycle and Diminishes the Infection of Mammalian Host Cells

Roberto I. Cuevas-Hernández, Richard M. B. M. Girard, Sarai Martínez-Cerón, et al.
Antimicrobial Agents and Chemotherapy 64 (2) (2020)
https://doi.org/10.1128/AAC.01742-19

Factors associated with Chagas screening among immigrants from an endemic country in Madrid, Spain

María Romay-Barja, Teresa Boquete, Obdulia Martinez, et al.
PLOS ONE 15 (3) e0230120 (2020)
https://doi.org/10.1371/journal.pone.0230120

Drug-cured experimental Trypanosoma cruzi infections confer long-lasting and cross-strain protection

Gurdip Singh Mann, Amanda F. Francisco, Shiromani Jayawardhana, et al.
PLOS Neglected Tropical Diseases 14 (4) e0007717 (2020)
https://doi.org/10.1371/journal.pntd.0007717

Mixed infections by different Trypanosoma cruzi discrete typing units among Chagas disease patients in an endemic community in Panama

Alexa Prescilla Ledezma, Roberto Blandon, Alejandro G. Schijman, et al.
PLOS ONE 15 (11) e0241921 (2020)
https://doi.org/10.1371/journal.pone.0241921

Re-evaluating pretomanid analogues for Chagas disease: Hit-to-lead studies reveal both in vitro and in vivo trypanocidal efficacy

Andrew M. Thompson, Patrick D. O’Connor, Andrew J. Marshall, et al.
European Journal of Medicinal Chemistry 207 112849 (2020)
https://doi.org/10.1016/j.ejmech.2020.112849

Diversity and genome mapping assessment of disordered and functional domains in trypanosomatids

Grace Santos Tavares Avelar, Leilane Oliveira Gonçalves, Frederico Gonçalves Guimarães, et al.
Journal of Proteomics 227 103919 (2020)
https://doi.org/10.1016/j.jprot.2020.103919

A Trypanosoma cruzi Genome Tandem Repetitive Satellite DNA Sequence as a Molecular Marker for a LAMP Assay for Diagnosing Chagas’ Disease

Diego Ordóñez, Pedro Fernández-Soto, Ana M. Fernández-Martín, et al.
Disease Markers 2020 1 (2020)
https://doi.org/10.1155/2020/8074314

Role of FAK signaling in chagasic cardiac hypertrophy

Amanda R. Tucci, Francisco O. R. de Oliveira, Guilherme C. Lechuga, et al.
The Brazilian Journal of Infectious Diseases 24 (5) 386 (2020)
https://doi.org/10.1016/j.bjid.2020.08.007

Searching for drugs for Chagas disease, leishmaniasis and schistosomiasis: a review

Soraya Silva Santos, Renan Vinicius de Araújo, Jeanine Giarolla, Omar El Seoud and Elizabeth Igne Ferreira
International Journal of Antimicrobial Agents 55 (4) 105906 (2020)
https://doi.org/10.1016/j.ijantimicag.2020.105906

Risk Score for Predicting 2‐Year Mortality in Patients With Chagas Cardiomyopathy From Endemic Areas: SaMi‐Trop Cohort Study

Claudia Di Lorenzo Oliveira, Maria Carmo P. Nunes, Enrico Antonio Colosimo, Emilly Malveira de Lima, Clareci S. Cardoso, Ariela Mota Ferreira, Lea Campos de Oliveira, Carlos Henrique Valente Moreira, Ana Luiza Bierrenbach, Desireé Sant′Ana Haikal, Sérgio Viana Peixoto, Maria Fernanda Lima‐Costa, Ester Cerdeira Sabino and Antonio Luiz P. Ribeiro
Journal of the American Heart Association 9 (6) (2020)
https://doi.org/10.1161/JAHA.119.014176

MicroRNAs: Biological Regulators in Pathogen–Host Interactions

Stephanie Maia Acuña, Lucile Maria Floeter-Winter and Sandra Marcia Muxel
Cells 9 (1) 113 (2020)
https://doi.org/10.3390/cells9010113

Benznidazole as Prophylaxis for Chagas Disease Infection Reactivation in Heart Transplant Patients: A Case Series in Brazil

Joao Manoel Rossi Neto, Marco Aurelio Finger and Carolina Casadei dos Santos
Tropical Medicine and Infectious Disease 5 (3) 132 (2020)
https://doi.org/10.3390/tropicalmed5030132

Chagas Disease Treatment and Rational Drug Discovery: A Challenge That Remains

Ana Catarina Cristovão Silva, Maria Carolina Accioly Brelaz-de-Castro, Ana Cristina Lima Leite, Valéria Rêgo Alves Pereira and Marcelo Zaldini Hernandes
Frontiers in Pharmacology 10 (2019)
https://doi.org/10.3389/fphar.2019.00873

Community-based surveillance and control of chagas disease vectors in remote rural areas of the Argentine Chaco: A five-year follow-up

María C. Cecere, Lucía I. Rodríguez-Planes, Gonzalo M. Vazquez-Prokopec, Uriel Kitron and Ricardo E. Gürtler
Acta Tropica 191 108 (2019)
https://doi.org/10.1016/j.actatropica.2018.12.038

Elucidating diversity in the class composition of the minicircle hypervariable region of Trypanosoma cruzi: New perspectives on typing and kDNA inheritance

Fanny Rusman, Nicolás Tomasini, Noelia-Floridia Yapur, et al.
PLOS Neglected Tropical Diseases 13 (6) e0007536 (2019)
https://doi.org/10.1371/journal.pntd.0007536

Inhibition of C. albicans Dimorphic Switch by Cobalt(II) Complexes with Ligands Derived from Pyrazoles and Dinitrobenzoate: Synthesis, Characterization and Biological Activity

Daniela Fonseca, Sandra M. Leal-Pinto, Martha V. Roa-Cordero, José D. Vargas, Erika M. Moreno-Moreno, Mario A. Macías, Leopoldo Suescun, Álvaro Muñoz-Castro and John J. Hurtado
International Journal of Molecular Sciences 20 (13) 3237 (2019)
https://doi.org/10.3390/ijms20133237

The fecal, oral, and skin microbiota of children with Chagas disease treated with benznidazole

Carlos Robello, Doris Patricia Maldonado, Anna Hevia, et al.
PLOS ONE 14 (2) e0212593 (2019)
https://doi.org/10.1371/journal.pone.0212593

Trypanosoma cruzi immunoproteome: Calpain-like CAP5.5 differentially detected throughout distinct stages of human Chagas disease cardiomyopathy

Marcelle A. Caminha, Virginia Maria B. de Lorena, Wilson de Oliveira Júnior, et al.
Journal of Proteomics 194 179 (2019)
https://doi.org/10.1016/j.jprot.2018.11.019

Gurdip Singh Mann, Amanda F. Francisco, Shiromani Jayawardhana, Martin C. Taylor, Michael D. Lewis, Francisco Olmo, Elisangela Oliveira de Freitas, Fabiana M. S. Leoratti, Cesar López-Camacho, Arturo Reyes-Sandoval and John M. Kelly
(2019)
https://doi.org/10.1101/741462

Potential Utility of Protein Targets of Cysteine-S-Nitrosylation in Identifying Clinical Disease Status in Human Chagas Disease

Maria Paola Zago, John E. Wiktorowicz, Heidi Spratt, et al.
Frontiers in Microbiology 9 (2019)
https://doi.org/10.3389/fmicb.2018.03320

Increased frequencies of circulating CCR5+ memory T cells are correlated to chronic chagasic cardiomyopathy progression

Ester Roffe, Luara I Dos Santos, Maykon O Santos, et al.
Journal of Leukocyte Biology 106 (3) 641 (2019)
https://doi.org/10.1002/JLB.MA1118-472R

Chagas Disease: From Discovery to a Worldwide Health Problem

Kárita Cláudia Freitas Lidani, Fabiana Antunes Andrade, Lorena Bavia, et al.
Frontiers in Public Health 7 (2019)
https://doi.org/10.3389/fpubh.2019.00166

Advances in understanding the role of adipose tissue and mitochondrial oxidative stress in Trypanosoma cruzi infection

Jyothi F. Nagajyothi and Louis M. Weiss
F1000Research 8 1152 (2019)
https://doi.org/10.12688/f1000research.19190.1

Glucocorticoids and sympathetic neurotransmitters modulate the acute immune response to Trypanosoma cruzi

Eduardo Roggero, Adriana del Rey, Johannes Wildmann and Hugo Besedovsky
Annals of the New York Academy of Sciences 1437 (1) 83 (2019)
https://doi.org/10.1111/nyas.13946

A reduction in ecological niche for Trypanosoma cruzi-infected triatomine bugs

Guiehdani Villalobos, Angela Nava-Bolaños, José A. De Fuentes-Vicente, et al.
Parasites & Vectors 12 (1) (2019)
https://doi.org/10.1186/s13071-019-3489-5

A Combination of Itraconazole and Amiodarone Is Highly Effective against Trypanosoma cruzi Infection of Human Stem Cell–Derived Cardiomyocytes

Gabriele Sass, Roy T. Madigan, Lydia-Marie Joubert, et al.
The American Journal of Tropical Medicine and Hygiene 101 (2) 383 (2019)
https://doi.org/10.4269/ajtmh.19-0023

The Trypanosoma cruzi RNA-binding protein RBP42 is expressed in the cytoplasm throughout the life cycle of the parasite

R. Tyler Weisbarth, Anish Das, Paul Castellano, et al.
Parasitology Research 117 (4) 1095 (2018)
https://doi.org/10.1007/s00436-018-5787-9

Solid Organ Transplant and Parasitic Diseases: A Review of the Clinical Cases in the Last Two Decades

Silvia Fabiani, Simona Fortunato and Fabrizio Bruschi
Pathogens 7 (3) 65 (2018)
https://doi.org/10.3390/pathogens7030065

Pyrazinoates as antiparasitic agents against Trypanosoma cruzi

Camilla I. Vasconcelos, Marina T. Varela, Ana C. Torrecilhas and João P. S. Fernandes
Archiv der Pharmazie 351 (11) (2018)
https://doi.org/10.1002/ardp.201800190

Benefits of Ascorbic Acid in Association with Low-Dose Benznidazole in Treatment of Chagas Disease

Maiara Voltarelli Providello, Zumira Aparecida Carneiro, Gisele Bulhões Portapilla, et al.
Antimicrobial Agents and Chemotherapy 62 (9) (2018)
https://doi.org/10.1128/AAC.00514-18

Are the London Declaration’s 2020 goals sufficient to control Chagas disease?: Modeling scenarios for the Yucatan Peninsula

Bruce Y. Lee, Sarah M. Bartsch, Laura Skrip, et al.
PLOS Neglected Tropical Diseases 12 (3) e0006337 (2018)
https://doi.org/10.1371/journal.pntd.0006337

Early Trypanosoma cruzi Infection Triggers mTORC1-Mediated Respiration Increase and Mitochondrial Biogenesis in Human Primary Cardiomyocytes

M. Gabriela Libisch, Paula Faral-Tello, Nisha J. Garg, et al.
Frontiers in Microbiology 9 (2018)
https://doi.org/10.3389/fmicb.2018.01889

Molecular description of α‐keto‐based inhibitors of cruzain with activity against Chagas disease combining 3D‐QSAR studies and molecular dynamics

Ádria P. B. Saraiva, Ricardo M. Miranda, Renan P. P. Valente, Jéssica O. Araújo, Rutelene N. B. Souza, Clauber H. S. Costa, Amanda R. S. Oliveira, Michell O. Almeida, Antonio F. Figueiredo, João E. V. Ferreira, Cláudio Nahum Alves and Kathia M. Honorio
Chemical Biology & Drug Design 92 (2) 1475 (2018)
https://doi.org/10.1111/cbdd.13313

2,4-Diamino-6-methylpyrimidines for the potential treatment of Chagas’ disease

Michael G. Thomas, Manu De Rycker, Ignacio Cotillo Torrejon, et al.
Bioorganic & Medicinal Chemistry Letters 28 (18) 3025 (2018)
https://doi.org/10.1016/j.bmcl.2018.08.005

Electrocardiographic abnormalities in Chagas disease in the general population: A systematic review and meta-analysis

Lyda Z. Rojas, Marija Glisic, Laura Pletsch-Borba, et al.
PLOS Neglected Tropical Diseases 12 (6) e0006567 (2018)
https://doi.org/10.1371/journal.pntd.0006567

Kinetics, subcellular localization, and contribution to parasite virulence of a Trypanosoma cruzi hybrid type A heme peroxidase ( Tc APx-CcP)

Martín Hugo, Alejandra Martínez, Madia Trujillo, et al.
Proceedings of the National Academy of Sciences 114 (8) (2017)
https://doi.org/10.1073/pnas.1618611114

Diet regulates liver autophagy differentially in murine acute Trypanosoma cruzi infection

Kezia Lizardo, Vanessa Almonte, Calvin Law, et al.
Parasitology Research 116 (2) 711 (2017)
https://doi.org/10.1007/s00436-016-5337-2

Antitrypanosomal activity and evaluation of the mechanism of action of dehydrodieugenol isolated from Nectandra leucantha (Lauraceae) and its methylated derivative against Trypanosoma cruzi

Simone S. Grecco, Thais A. Costa-Silva, Gerold Jerz, et al.
Phytomedicine 24 62 (2017)
https://doi.org/10.1016/j.phymed.2016.11.015

Comparison of four PCR methods for efficient detection of Trypanosoma cruzi in routine diagnostics

Peter Seiringer, Michael Pritsch, María Flores-Chavez, et al.
Diagnostic Microbiology and Infectious Disease 88 (3) 225 (2017)
https://doi.org/10.1016/j.diagmicrobio.2017.04.003

Chagas Disease Infection among Migrants at the Mexico/Guatemala Border

Erin E. Conners, Carmen Fernández Casanueva, Sonia Morales Miranda, et al.
The American Journal of Tropical Medicine and Hygiene 97 (4) 1134 (2017)
https://doi.org/10.4269/ajtmh.16-0777

Challenges in the chemotherapy of Chagas disease: Looking for possibilities related to the differences and similarities between the parasite and host

Vitor Sueth-Santiago, Debora Decote-Ricardo, Alexandre Morrot, Celio Geraldo Freire-de-Lima and Marco Edilson Freire Lima
World Journal of Biological Chemistry 8 (1) 57 (2017)
https://doi.org/10.4331/wjbc.v8.i1.57

Sylvatic host associations of Triatominae and implications for Chagas disease reservoirs: a review and new host records based on archival specimens

Anna Y. Georgieva, Eric R.L. Gordon and Christiane Weirauch
PeerJ 5 e3826 (2017)
https://doi.org/10.7717/peerj.3826

Subverting Host Cell P21-Activated Kinase: A Case of Convergent Evolution across Pathogens

Simona John Von Freyend, Terry Kwok-Schuelein, Hans Netter, Gholamreza Haqshenas, Jean-Philippe Semblat and Christian Doerig
Pathogens 6 (2) 17 (2017)
https://doi.org/10.3390/pathogens6020017

Cysteine mutagenesis improves the production without abrogating antigenicity of a recombinant protein vaccine candidate for human chagas disease

Christopher A. Seid, Kathryn M. Jones, Jeroen Pollet, et al.
Human Vaccines & Immunotherapeutics 13 (3) 621 (2017)
https://doi.org/10.1080/21645515.2016.1242540

Discovery and Optimization of 5-Amino-1,2,3-triazole-4-carboxamide Series against Trypanosoma cruzi

Stephen Brand, Eun Jung Ko, Elisabet Viayna, et al.
Journal of Medicinal Chemistry 60 (17) 7284 (2017)
https://doi.org/10.1021/acs.jmedchem.7b00463

6-Nitro-2,3-dihydroimidazo[2,1-b][1,3]thiazoles: Facile synthesis and comparative appraisal against tuberculosis and neglected tropical diseases

Andrew M. Thompson, Adrian Blaser, Brian D. Palmer, Robert F. Anderson, Sujata S. Shinde, Delphine Launay, Eric Chatelain, Louis Maes, Scott G. Franzblau, Baojie Wan, Yuehong Wang, Zhenkun Ma and William A. Denny
Bioorganic & Medicinal Chemistry Letters 27 (11) 2583 (2017)
https://doi.org/10.1016/j.bmcl.2017.03.069

Benznidazole treatment safety: the Médecins Sans Frontières experience in a large cohort of Bolivian patients with Chagas' disease

Gilberto Marcelo Sperandio da Silva, Mauro Felippe Felix Mediano, Alejandro Marcel Hasslocher-Moreno, et al.
Journal of Antimicrobial Chemotherapy 72 (9) 2596 (2017)
https://doi.org/10.1093/jac/dkx180

Trans-Sialidase Overcomes Many Antigens to be Used as a Vaccine Candidate Against Trypanosoma Cruzi

Ivan Bontempi, Pedro Fleitas, Alexia Poato, Miguel Vicco, Luz Rodeles, Estefania Prochetto, Gabriel Cabrera, Bruno Beluzzo, Diego Arias, Andrea Racca, Sergio Guerrero and Iván Marcipar
Immunotherapy 9 (7) 555 (2017)
https://doi.org/10.2217/imt-2017-0009

Lysosomes - Associated Diseases and Methods to Study Their Function

Barbara Hissa and Luciana O. Andrade
Lysosomes - Associated Diseases and Methods to Study Their Function (2017)
https://doi.org/10.5772/intechopen.69305

The Complement System: A Prey of Trypanosoma cruzi

Kárita C. F. Lidani, Lorena Bavia, Altair R. Ambrosio and Iara J. de Messias-Reason
Frontiers in Microbiology 8 (2017)
https://doi.org/10.3389/fmicb.2017.00607

Assessing the Archaeoparasitological Potential of Quids As a Source Material for Immunodiagnostic Analyses

Johnica J. Morrow and Karl J. Reinhard
The Korean Journal of Parasitology 54 (5) 605 (2016)
https://doi.org/10.3347/kjp.2016.54.5.605

In vitro screening of 2-(1H-imidazol-1-yl)-1-phenylethanol derivatives as antiprotozoal agents and docking studies on Trypanosoma cruzi CYP51

Daniela De Vita, Francesca Moraca, Claudio Zamperini, et al.
European Journal of Medicinal Chemistry 113 28 (2016)
https://doi.org/10.1016/j.ejmech.2016.02.028

The sympathetic nervous system affects the susceptibility and course of Trypanosoma cruzi infection

Eduardo Roggero, Ana Rosa Pérez, Natalia Pollachini, et al.
Brain, Behavior, and Immunity 58 228 (2016)
https://doi.org/10.1016/j.bbi.2016.07.163